Please login to the form below

Not currently logged in
Email:
Password:

ISPE looks to Boehringer for new VP of Europe

Thomas Zimmer was senior VP at German pharma company
ispe thomas zimmer

Thomas Zimmer has left his senior VP role at Boehringer Ingelheim to join the International Society for Pharmaceutical Engineering (ISPE) as VP of European operations.

In his new role, Zimmer will be responsible for leading ISPE's business development and advancing strategic relationships in Europe.

He spent 32 years at German pharma company Boehringer, serving in senior roles across development, production, quality and supply chain management

In addition, Zimmer has experience at the European Federations of Pharmaceutical Industry Associations (EFPIA) and as a member of the World Health Organization's (WHO) IMPACT taskforce.

"Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large," said ISPE President and CEO Nancy Berg.

"Thomas's first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world."

14th November 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics